Nosolin-Balzam

Nosolin-Balzam is a nasal decongestant developed by the pharmaceutical company Firn M. Its active ingredient is xylometazoline, a small molecule alpha-adrenergic agonist. When applied topically to the nasal mucosa, xylometazoline stimulates alpha-adrenergic receptors, leading to local vasoconstriction of the blood vessels. This action reduces swelling (edema) and congestion, facilitating easier breathing. It is primarily indicated for the symptomatic treatment of rhinitis and nasal mucosal edema. The product is marketed in Russia and is typically formulated as a nasal spray or solution for intranasal administration.

Brand names

Nosolin-BalzamНосолин-бальзам

Other names

Nosolin-balzam